Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression

Abnormalities in the handling of intracellular bacteria in Crohn’s disease: a link between infectious etiology and host genetic susceptibility

(2008) Anne-Lise Glasser et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Metagenomic Approaches for Defining the Pathogenesis of Inflammatory Bowel Diseases

(2008) Daniel A. Peterson et al.   Cell Host & Microbe

Extraintestinal manifestations of inflammatory bowel disease

(2008) S. Ardizzone et al.   DIGESTIVE AND LIVER DISEASE

Microbial Influences in Inflammatory Bowel Diseases

(2008) R. Balfour Sartor   GASTROENTEROLOGY

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis

(2008) Michael A. Kamm et al.   INFLAMMATORY BOWEL DISEASES

Gut microbiota: a potential new territory for drug targeting

(2008) Wei Jia et al.   NATURE REVIEWS DRUG DISCOVERY

Evolution of Mammals and Their Gut Microbes

(2008) R. E. Ley et al.   SCIENCE

Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: A clinical review and update

(2007) David T. Rubin et al.   INFLAMMATORY BOWEL DISEASES

Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine

(2007) Sreedhar Subramanian et al.   INFLAMMATORY BOWEL DISEASES